Berkshire, United Kingdom

Jonathan Kenneth Embleton

This inventor holds 5 USPTO granted patents. Top assignees: R.p. Scherer Corporation, Pharmacia Aktiebolag. Active years: 1997-2004.


% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 5

Forward Citations = 746(Granted Patents)


Location History:

  • Berkshire, GB (1997 - 2000)
  • Cirencester, GB (2001)
  • Newbury, GB (2002 - 2004)

Company Filing History:


Years Active: 1997-2004

Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Jonathan Kenneth Embleton

Introduction

Jonathan Kenneth Embleton is a notable inventor based in Berkshire, GB. He has made significant contributions to the field of ocular treatment, holding a total of 5 patents. His innovative designs focus on improving the delivery of treatment fluids through advanced container technology.

Latest Patents

One of his latest patents is an ocular treatment device that features a unit container for a treatment fluid. This container comprises a sealed enclosure with at least one opening in one wall section. The enclosure is designed to be pressurizable, allowing it to discharge its contents through the openings, which are of sufficient diameter to generate a jet or discrete droplets of treatment fluid. Typically, the wall section is a flat section of the enclosure wall, and the enclosure is often a blister pack. However, it can also be dome-shaped with openings in the top region. These containers can be packaged in various forms, such as strip form or planar arrays, and dispensing devices are described for effective treatment delivery.

Career Highlights

Throughout his career, Jonathan has worked with reputable companies, including R.P. Scherer Corporation and Pharmacia Aktiebolag. His experience in these organizations has contributed to his expertise in developing innovative treatment solutions.

Collaborations

Jonathan has collaborated with notable individuals in his field, including Jonathan Ernest Lacy and Stephen P. Jones. These partnerships have likely enhanced his work and led to further advancements in ocular treatment technologies.

Conclusion

Jonathan Kenneth Embleton's contributions to ocular treatment innovation demonstrate his commitment to improving healthcare solutions. His patents reflect a deep understanding of the needs in this field and a drive to create effective treatment delivery systems.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…